![](/img/cover-not-exists.png)
A phase 2 study of the cytotoxic immunoconjugate CMB-401 (hCTM01-calicheamicin) in patients with platinum-sensitive recurrent epithelial ovarian carcinoma
Stephen Y. Chan, Alan N. Gordon, Robert E. Coleman, James B. Hall, Mark S. Berger, Matthew L. Sherman, Catharine B. Eten, Neil J. FinklerVolume:
52
Language:
english
Pages:
6
DOI:
10.1007/s00262-002-0343-x
Date:
April, 2003
File:
PDF, 183 KB
english, 2003